| IL-17 signaling pathway |
2.35 |
0.00e+0 |
84/94 (89.36%) |
CXCL8;FOSB;NFKBIA;...
|
| TNF signaling pathway |
2.34 |
0.00e+0 |
103/112 (91.96%) |
NFKBIA;FOS;CXCL2;...
|
| Chronic myeloid leukemia |
2.16 |
0.00e+0 |
72/76 (94.74%) |
GADD45B;NFKBIA;CDKN1A;...
|
| FoxO signaling pathway |
2.12 |
0.00e+0 |
118/131 (90.08%) |
GADD45B;CDKN1A;IL6;...
|
| TGF-beta signaling pathway |
2.10 |
0.00e+0 |
81/94 (86.17%) |
BMP2;THBS1;ID4;...
|
| Bladder cancer |
2.08 |
0.00e+0 |
40/41 (97.56%) |
CXCL8;THBS1;CDKN1A;...
|
| Rheumatoid arthritis |
2.06 |
0.00e+0 |
78/93 (83.87%) |
CXCL8;FOS;CXCL2;...
|
| Epithelial cell signaling in Helicobacter pylori infect... |
2.05 |
0.00e+0 |
62/70 (88.57%) |
CXCL8;NFKBIA;CXCL2;...
|
| AGE-RAGE signaling pathway in diabetic complications |
2.04 |
0.00e+0 |
97/100 (97%) |
CXCL8;EGR1;IL6;...
|
| Kaposi sarcoma-associated herpesvirus infection |
1.99 |
1.10e-3 |
172/193 (89.12%) |
CXCL8;NFKBIA;FOS;...
|
| Endometrial cancer |
1.96 |
3.00e-3 |
56/58 (96.55%) |
GADD45B;CDKN1A;GADD45A;...
|
| Colorectal cancer |
1.95 |
3.67e-3 |
84/86 (97.67%) |
GADD45B;AREG;FOS;...
|
| Small cell lung cancer |
1.91 |
5.08e-3 |
90/92 (97.83%) |
GADD45B;NFKBIA;PTGS2;...
|
| NF-kappa B signaling pathway |
1.90 |
4.72e-3 |
90/104 (86.54%) |
CXCL8;GADD45B;NFKBIA;...
|
| Adherens junction |
1.88 |
4.40e-3 |
63/71 (88.73%) |
INSR;SMAD3;ACTN4;...
|
| NOD-like receptor signaling pathway |
1.87 |
4.81e-3 |
145/181 (80.11%) |
CXCL8;NFKBIA;CXCL2;...
|
| Prostate cancer |
1.83 |
6.47e-3 |
93/97 (95.88%) |
NFKBIA;CDKN1A;GSTP1;...
|
| Breast cancer |
1.76 |
1.53e-2 |
119/147 (80.95%) |
GADD45B;FOS;CDKN1A;...
|
| Cytosolic DNA-sensing pathway |
1.75 |
1.80e-2 |
52/63 (82.54%) |
NFKBIA;IL6;NFKBIB;...
|
| Basal cell carcinoma |
1.75 |
1.76e-2 |
41/63 (65.08%) |
GADD45B;BMP2;CDKN1A;...
|
| Malaria |
1.74 |
1.94e-2 |
44/50 (88%) |
CXCL8;THBS1;IL6;...
|
| PI3K-Akt signaling pathway |
1.74 |
2.05e-2 |
317/354 (89.55%) |
AREG;NR4A1;THBS1;...
|
| Cellular senescence |
1.74 |
2.01e-2 |
139/156 (89.1%) |
CXCL8;GADD45B;CDKN1A;...
|
| Hippo signaling pathway |
1.73 |
1.93e-2 |
120/186 (64.52%) |
CCN2;AREG;BMP2;...
|
| Thyroid cancer |
1.73 |
1.85e-2 |
36/37 (97.3%) |
GADD45B;CDKN1A;GADD45A;...
|
| Gastric cancer |
1.72 |
2.07e-2 |
122/149 (81.88%) |
GADD45B;CDKN1A;GADD45A;...
|
| B cell receptor signaling pathway |
1.72 |
2.00e-2 |
71/81 (87.65%) |
NFKBIA;FOS;JUN;...
|
| Hepatitis B |
1.70 |
2.40e-2 |
151/162 (93.21%) |
CXCL8;NFKBIA;FOS;...
|
| Pancreatic cancer |
1.69 |
2.39e-2 |
75/76 (98.68%) |
GADD45B;CDKN1A;VEGFA;...
|
| Epstein-Barr virus infection |
1.69 |
2.31e-2 |
189/202 (93.56%) |
GADD45B;NFKBIA;TNFAIP3;...
|
| ABC transporters |
-1.59 |
4.70e-2 |
37/45 (82.22%) |
ABCG1;ABCA8;ABCA12;...
|
| Steroid hormone biosynthesis |
-1.60 |
4.41e-2 |
43/61 (70.49%) |
SRD5A1;AKR1C4;HSD3B1;...
|
| Histidine metabolism |
-1.63 |
4.05e-2 |
16/22 (72.73%) |
ALDH1B1;ALDH3A2;AOC1;...
|
| Propanoate metabolism |
-1.65 |
3.55e-2 |
30/34 (88.24%) |
DLD;HIBCH;PCCA;...
|
| Metabolism of xenobiotics by cytochrome P450 |
-1.67 |
3.00e-2 |
49/77 (63.64%) |
UGT2B17;MGST2;GSTA1;...
|
| Starch and sucrose metabolism |
-1.67 |
3.12e-2 |
25/36 (69.44%) |
GBA3;HKDC1;SI;...
|
| Fanconi anemia pathway |
-1.68 |
3.26e-2 |
36/54 (66.67%) |
CENPX;FAAP100;FANCG;...
|
| Citrate cycle (TCA cycle) |
-1.68 |
3.24e-2 |
30/30 (100%) |
SUCLG2;SDHB;ACLY;...
|
| Mucin type O-glycan biosynthesis |
-1.69 |
3.08e-2 |
20/36 (55.56%) |
ST3GAL2;GALNT11;C1GALT1C1;...
|
| Fatty acid degradation |
-1.71 |
2.98e-2 |
40/43 (93.02%) |
CPT1A;ALDH1B1;ALDH3A2;...
|
| Arachidonic acid metabolism |
-1.71 |
3.22e-2 |
48/61 (78.69%) |
PTGS1;PTGIS;LTA4H;...
|
| beta-Alanine metabolism |
-1.73 |
3.03e-2 |
25/30 (83.33%) |
HIBCH;ALDH1B1;ALDH3A2;...
|
| Mismatch repair |
-1.76 |
2.07e-2 |
22/23 (95.65%) |
EXO1;POLD4;MSH3;...
|
| Homologous recombination |
-1.81 |
1.20e-2 |
35/41 (85.37%) |
POLD4;RAD51D;RAD51;...
|
| Ascorbate and aldarate metabolism |
-1.83 |
1.24e-2 |
15/30 (50%) |
ALDH1B1;AKR1A1;ALDH3A2;...
|
| Amino sugar and nucleotide sugar metabolism |
-1.86 |
9.00e-3 |
38/48 (79.17%) |
GALE;HKDC1;GALT;...
|
| Folate biosynthesis |
-1.89 |
6.00e-3 |
23/26 (88.46%) |
SPR;MOCOS;MOCS2;...
|
| Pyruvate metabolism |
-1.89 |
7.20e-3 |
41/47 (87.23%) |
ADH6;GRHPR;ADH7;...
|
| Glycolysis / Gluconeogenesis |
-1.95 |
2.25e-3 |
56/67 (83.58%) |
DLD;HK1;G6PC3;...
|
| Pentose and glucuronate interconversions |
-1.96 |
3.00e-3 |
17/34 (50%) |
UGT2B17;UGT2B4;UGT2B15;...
|
| Peroxisome |
-2.06 |
0.00e+0 |
72/82 (87.8%) |
PEX19;PEX6;MPV17;...
|
| Porphyrin and chlorophyll metabolism |
-2.19 |
0.00e+0 |
23/43 (53.49%) |
ALAS1;PPOX;UGT2B17;...
|
